Optimizing Vancomycin Therapy: A Comprehensive Review
Authors: Abdulaziz Alamri, Ahmad Bawazeer, Tariq Almotiri, Sattam Alharbi, Delyal Alshammari, Bader Alnasser, Hani Alswayeh
DOI: https://doi.org/10.5281/zenodo.13482135
Short DOI: https://doi.org/gt76kj
Country: Saudi Arabia
Full-text Research PDF File: View | Download
Abstract:
Vancomycin, a glycopeptide antibiotic, has long been a mainstay in the treatment of serious Gram-positive infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA) [1]. As antibiotic resistance continues to rise globally, the judicious use of vancomycin has become increasingly critical to prevent the emergence of further resistance and ensure the continued efficacy of this important drug [2].
Effective management of vancomycin therapy requires a multifaceted approach, including appropriate dosing, monitoring of serum concentrations, and management of adverse effects. This review will provide a comprehensive overview of the current best practices in vancomycin therapy, drawing on the latest clinical evidence and guidelines.
Keywords: NA
Paper Id: 231072
Published On: 2018-06-04
Published In: Volume 6, Issue 3, May-June 2018
Cite This: Optimizing Vancomycin Therapy: A Comprehensive Review - Abdulaziz Alamri, Ahmad Bawazeer, Tariq Almotiri, Sattam Alharbi, Delyal Alshammari, Bader Alnasser, Hani Alswayeh - IJIRMPS Volume 6, Issue 3, May-June 2018. DOI 10.5281/zenodo.13482135